Evidence map›Paper›PMID 36001043›Full record

ArticleThe Journal of general physiology2022

Molecular-level evidence of force maintenance by smooth muscle myosin during LC20 dephosphorylation.

Megan Jean Hammell, Linda Kachmar, Zsombor Balassy, Gijs IJpma, Anne-Marie Lauzon

Open access · greenAbstract read
In one paragraph

Article in The Journal of general physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Megan Jean HammellDepartment of Biological and Biomedical Engineering, McGill University, Montreal, Quebec, Canada.
Linda KachmarResearch Institute of the McGill University Health Centre, Meakins-Christie Laboratories, Montreal, Quebec, Canada.ORCID 0000-0001-8304-3820
Zsombor BalassyDepartment of Biological and Biomedical Engineering, McGill University, Montreal, Quebec, Canada.
Gijs IJpmaResearch Institute of the McGill University Health Centre, Meakins-Christie Laboratories, Montreal, Quebec, Canada.ORCID 0000-0001-9919-8907
Anne-Marie LauzonDepartment of Biological and Biomedical Engineering, McGill University, Montreal, Quebec, Canada.ORCID 0000-0003-1199-7259
McGill University Health Centre · CA

Funding

Le Fonds de la Recherche en Santé du QuébecMcGill UniversityNatural Sciences and Engineering Research Council of Canada RGPIN-2015-05054
6 · The paper itself

Abstract

Smooth muscle (SM) is found in most hollow organs of the body. Phasic SM, as found in the gut, contracts to propel content, whereas tonic SM, as found in most blood vessels, maintains tension. This force maintenance is referred to as the latch state and occurs at low levels of myosin activation (myosin light chain [LC20] phosphorylation). Molecular mechanisms have been proposed to explain the latch state but have been studied only at the whole-muscle level because of technological limitations. In the current study, an assay chamber was devised to allow injection of myosin light chain phosphatase (MLCP) during laser trap and in vitro motility assays, without creating bulk flow, to reproduce latch state conditions at the molecular level. Using the laser trap in a single-beam mode, an actin filament was brought in contact with several myosin molecules on a pedestal. Myosin pulled on the actin filament until a plateau force was reached, at which point, MLCP was injected. Force maintenance was observed during LC20 dephosphorylation, the level of which was assessed in a parallel in vitro motility assay performed in the same conditions. Force was maintained longer for myosin purified from tonic SM than from phasic SM. These data support the longstanding dogma of strong bonds caused by dephosphorylated, noncycling cross-bridges. Furthermore, MLCP injection in an in vitro motility mixture assay performed with SM and skeletal muscle myosin suggests that the maintenance of these strong bonds is possible only if no energy is provided by surrounding actively cycling myosin molecules.

Indexed as

Muscle, SmoothSmooth Muscle MyosinsMuscle ContractionMyosin-Light-Chain PhosphataseMyosin Light ChainsPhosphorylationMyosin-Light-Chain PhosphataseMyosin Light ChainsSmooth Muscle Myosins

Identifiers

PMID36001043
PMCPMC9411650
OpenAlexW4293102144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.